Lilies of the Valley got its start in 2004 when a new gynecologic oncologist moved to the city of Huntsville, Alabama. His wife had a friend with ovarian cancer, and she noticed that there were no support groups available for women with this disease. Current Executive Director Regina Parker recalls: “She got together with some … Continued
(Sept. 29, 2014) In a perspective piece for the website MedPage Today, representatives from the Society of Gynecologic Oncology discuss clinical endpoints appropriate for studies addressing the “unique characteristics” of ovarian cancer and progress toward improving outcomes for women affected by the disease. In the article, co-authors Thomas J. Herzog, MD, of the University of Cincinnati … Continued
(Sept. 25, 2014) Maintenance therapy with the oral agent pazopanib improved progression free survival (PFS) by a median of 5.6 months in patients with advanced ovarian cancer but did not impact overall survival, according to the results of a phase III randomized trial reported in the Journal of Clinical Oncology. In this clinical trial, which … Continued
A new study in the Journal of Clinical Investigation indicates that mesothelial cells actively promote the spread of ovarian cancer. Using a three dimensional culture model of ovarian cancer metastasis, OCRF grantee and Scientific Advisory Committee Member Ernst Lengyel, MD, PhD, and colleagues at the Unviersity of Chicago found that in the presence of cancer … Continued
A Collaboration of Stand Up To Cancer, Ovarian Cancer Research Fund, Ovarian Cancer National Alliance and National Ovarian Cancer Coalition PHILADELPHIA — The American Association for Cancer Research (AACR) is now accepting submissions of ideas for the Stand Up To Cancer (SU2C)-Ovarian Cancer Research Fund (OCRF)-Ovarian Cancer National Alliance (OCNA)-National Ovarian Cancer Coalition (NOCC) Translational … Continued
The American Association for Cancer Research is now accepting submissions of ideas for the new Stand Up To Cancer Ovarian Cancer Translational Research Dream Team Grant that will offer up to $6 million in research funding, which includes $3 million provided by the leading funder, OCRF. The Stand Up To Cancer-Ovarian Cancer Research Fund-Ovarian Cancer … Continued
(September 12, 2014) A new study published in the Journal of the National Cancer Institute this month suggests that use of perineal powder does not influence ovarian cancer risk. In the past, some studies have suggested that there is an increased risk of ovarian cancer among talc users. In this new and large prospective study, … Continued
Ovarian Cancer Community Joins Forces to Fight Deadliest Gynecologic Cancer A groundbreaking collaboration among three national ovarian cancer organizations was announced during the Stand Up to Cancer telecast on Friday evening, September 5th. Ovarian Cancer Research Fund (OCRF), Ovarian Cancer National Alliance (OCNA), and National Ovarian Cancer Coalition (NOCC) have teamed up with Stand Up … Continued
From one ride in 2004, to a national event in 2014.
Gynecologic Cancer Patients to Receive New Support in Los Angeles, CA; Pittsburgh, PA; Stony Brook, NY and Chicago, IL WEST CHESTER, Pa (September 3, 2014) —Ovarian Cancer Research Fund (OCRF) and QVC today announced four new Woman to Woman grant recipients: City of Hope in Los Angeles, CA; Magee-Womens Hospital of University of Pittsburgh Medical … Continued
The NormaLeah Ovarian Cancer Foundation is named for two sisters who both died from ovarian cancer. Executive Director Jodie Shagrin Kavensky, one of Norma’s daughters, recalls that her mother attended a women’s cancer luncheon a few months before she passed away. “They never talked about ovarian cancer. As she was dying, my mother said, ‘Jodie, … Continued
(September 2, 2014) New research by researchers at the University of Chicago, including OCRF grantee and Scientific Advisory Committee member Ernst Lengyel, MD, PhD, investigated whether statin use is associated with improved epithelial ovarian cancer (OvCa) survival. The findings were published this month in PLoS One. The use of statins to lower cholesterol as a … Continued
Get email updates about research news, action alerts, and ways to join the fight.
Our website uses cookies to ensure you get the best experience. By continuing to use this website, you indicate that you have read and agree to our Terms of Use and Privacy Policy.
